Original Research
Published on 09 Oct 2020
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2020.573526
- 15,071 views
- 46 citations
